| Hans-Günter Meyer-Thompson | International
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Weimer, Melissa B. DO, MCR, DFASAM; Herring, Andrew A. MD; Kawasaki, Sarah S. MD, FASAM; Meyer, Marjorie MD; Kleykamp, Bethea A. PhD; Ramsey, Kelly S. MD, MPH, MA, FACP, DFASAM
Journal of Addiction Medicine 17(6):p 632-639, 11/12 2023. | DOI: 10.1097/ADM.0000000000001202
https://journals.lww.com/journaladdictionmedicine/fulltext/2023/11000/asam_clinical_considerations__buprenorphine.2.aspx